Rhinocort and Paleness - a phase IV clinical study of FDA data

Summary:

Paleness is reported as a side effect among people who take Rhinocort (budesonide), especially for people who are female, 60+ old, also take Paxil Cr, and have Stress and anxiety.

The phase IV clinical study analyzes which people have Paleness when taking Rhinocort. It is created by eHealthMe based on reports of 6,990 people who have side effects when taking Rhinocort from the FDA, and is updated regularly.

What is Rhinocort?

Rhinocort has active ingredients of budesonide. It is often used in allergies. eHealthMe is studying from 7,139 Rhinocort users. Check the latest studies of Rhinocort.

What is Paleness?

Paleness (unusual lightness of skin colour) is found to be associated with 1,566 drugs and 2,116 conditions by eHealthMe. Check the latest studies of Paleness.

On Jul, 13, 2026

6,990 people reported to have side effects when taking Rhinocort.
Among them, 23 people (0.33%) have Paleness.

Among these 23 people:

What is the gender of people who have Paleness when taking Rhinocort? *

female: 72.73 %
male: 27.27 %

What is the age of people who have Paleness when taking Rhinocort? *

What are other drugs people take besides Rhinocort? *

What are other side effects people have besides Paleness? *

Dyspnea (difficult or laboured breathing): 11 people, 47.83%
Weakness: 9 people, 39.13%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 7 people, 30.43%
Haematocrit Decreased: 6 people, 26.09%
Meconium In Amniotic Fluid: 6 people, 26.09%
Foetal Distress Syndrome (altered heart rate or rhythm and leading tocompromised blood flow or changes in blood chemistry of foetus): 6 people, 26.09%
Drug Exposure During Pregnancy: 6 people, 26.09%
Developmental Delay: 6 people, 26.09%
Respiratory Distress (difficulty in breathing): 6 people, 26.09%
Hypotonia (low muscle tone): 6 people, 26.09%

What are the existing conditions these people have? *

Stress And Anxiety: 6 people, 26.09%
Gastric Disorder (disease of stomach): 3 people, 13.04%
Quit Smoking: 3 people, 13.04%
Hypersensitivity: 3 people, 13.04%
Aplastic Anemia: 2 people, 8.70%
Psychomotor Hyperactivity (feelings of extreme restlessness): 2 people, 8.70%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 8.70%
Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 2 people, 8.70%
Mycobacterium Abscessus Infection (rapid growing bacterial infection): 2 people, 8.70%
Urinary Tract Infection: 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Rhinocort and have Paleness?

- Check whether Paleness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rhinocort:

Rhinocort (7,139 reports)

Paleness treatments and more:

Paleness (34,670 reports)

Browse all side effects of Rhinocort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Paleness:

Paleness (1,566 drugs)

Browse all the conditions that are associated with Paleness:

Paleness (2,116 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on budesonide (the active ingredients of Rhinocort) and Rhinocort (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.